Monthly Archives: November 2019

Thinking Boldly: Alkermes Acquires Rodin Therapeutics
November 18, 2019

Today Alkermes announced its acquisition of Rodin Therapeutics, a leader in the field of synaptic dysfunction and neuronal epigenetics. Alkermes extensive experience in CNS diseases made them an ideal partner for Rodin, and this acquisition helps expand Alkermes’ efforts into

Leave a comment

The Promise Of Precision Neuroscience And Launch Of Arkuda Therapeutics
November 14, 2019

Neuroscience has had a tough run of news lately. With Amgen deprioritizing neuro this year, Pfizer doing the same last year, and others like BMS, GSK, and AZ cutting back on CNS a few years earlier, it would seem dark

Leave a comment